News & Analysis as of

Patent Portfolios Today's Popular Updates

Sunstein LLP

Trial Court Ruling Threatens Patent Portfolio Development

Sunstein LLP on

A recent decision by a San Francisco federal district court judge imperils the way many significant patent portfolios are developed. In Sonos v. Google, Judge William Alsup held that two patents asserted by Sonos against...more

MoFo Life Sciences

The Importance Of Patents For ML-Based Medical Device Inventions

MoFo Life Sciences on

The use of machine learning (ML) in the medical device field has greatly expanded in recent years, becoming increasingly important to the product offerings of many medical device companies....more

Fish & Richardson

Strategic IP Considerations of Batteries and Energy Storage Solutions

Fish & Richardson on

The lithium-ion battery, introduced commercially in 1991, revolutionized the consumer electronics industry. Compared with older battery technologies, the lithium-ion battery was lightweight and compact, had high energy...more

Foley & Lardner LLP

Leveraging E/AV Patent Portfolios During a Pandemic

Foley & Lardner LLP on

Like many industries, the pandemic has impacted the automotive industry, including electric and autonomous vehicle (E/AV) research and development. E/AV companies have laid off workers, delayed testing, and postponed the...more

Tucker Arensberg, P.C.

Dispute Between Telehealth Giants Heats Up

Tucker Arensberg, P.C. on

Teladoc has sued competitor Amwell over patent claims in the U.S. District Court for the District of Delaware. Teladoc is accusing Amwell of infringing on its patents related to telehealth carts, a digital scope and...more

White & Case LLP

Recent Uptick in Patent Litigation Likely Due to Coronavirus and Legal Developments

White & Case LLP on

White & Case Technology Newsflash - Companies with strong patent portfolios and those subject to infringement actions should note that patent litigation is on the rise. At the national level, 20Q2 patent filings were up 27...more

Haug Partners LLP

INSIGHT: Abbvie Defeats Novel Antitrust Claims Against Humira Patent Estate—Lessons Learned

Haug Partners LLP on

A federal district court recently dismissed a lawsuit against AbbVie and biosimilar manufacturers of adalimumab involving a novel antitrust claim against the Humira patent estate. Attorneys with Haug Partners LLP take an...more

American Conference Institute (ACI)

[Virtual Event] 18th Advanced Summit on Life Sciences Patents - August 5th - 6th, 9:00 am EDT

Perfect Your Patent Prosecution Strategies and Master the Patent Application Process in the U.S and Around the World. ACI’s 18th Global Summit on Life Sciences Patents virtual conference this August will provide practical...more

Foley & Lardner LLP

Remodeling your Artificial Intelligence IP Strategy: Top 3 reasons to invest in your IP

Foley & Lardner LLP on

Artificial intelligence has weaved its way into almost every industry, from detecting cancer to predicting employee performance to teaching robots and vehicles to use all kinds of sensor data to make human-like decisions in...more

Goodwin

Merck Transfers Biosimilars and Other Products to Spinoff Company

Goodwin on

Last week, Merck announced its intention to spin-off products from its Women’s Health, legacy brands, and biosimilars businesses into a new, yet-to-be-named, independent, publicly traded company.  According to Merck, “NewCo...more

Morgan Lewis

Medical Device Companies: Three Ways to Strengthen Your Design Patent Portfolio in 2020

Morgan Lewis on

Rapid advancements in medical device technology have brought unprecedented changes to the industry. Increasingly, innovative medical devices also combine developments from other industries such as software, hardware,...more

Shook, Hardy & Bacon L.L.P.

Audio Giant Silencing the Competition: Sonos Continues its Competitor-Centric Patent Offensive, this time against Bluesound and...

Fresh off the heels of a major patent infringement win against competitor Denon Electronics and their HEOS line of wireless multi-room audio systems, Sonos is now taking aim at Canada-based Lenbrook Industries Limited, the...more

Shook, Hardy & Bacon L.L.P.

IoT Lighting Industry Giants Hit with Patent Infringement Suit

TriDiNetworks, an Israel based cloud management platform for M2M (machine-to-machine) and IoT networks, recently filed three lawsuits against industry leaders in IoT technology for alleged willful patent infringement. Two of...more

Shook, Hardy & Bacon L.L.P.

Data Scape Launches Patent Ligation Campaign in United States and Europe against Leading Technology Companies on Cloud-based Data...

Data Scape Limited, a non-practicing entity based in Ireland, has recently filed a wave of patent infringement lawsuits in the United States and Germany against leading technology companies including...more

Hogan Lovells

Huawei v. Samsung — A new benchmark for standard essential patent litigation in China?

Hogan Lovells on

China has become a new battlefield in the global patent war amongst tech giants in the telecom industry. On 4 January 2018, the Shenzhen Intermediate People’s Court (“Court“) rendered a landmark judgment in the Huawei v....more

Shook, Hardy & Bacon L.L.P.

Cloud Cybersecurity Solutions Under Siege From Patents, Again: Cybersecurity Companies Protect Customers From Malicious Attacks,...

In yet another twist of competitor-based lawsuits involving cloud-based cybersecurity, relative newcomer CUPP Computing AS (a Norwegian company) and its American counterpart CUPP Cybersecurity filed a patent lawsuit against...more

Shook, Hardy & Bacon L.L.P.

Ribbon Communications Files Two More Lawsuits against Metaswitch In Ongoing Patent Battle

Cloud competitor cases are definitely on the rise over the past year. We’ve seen patent infringement lawsuits from established cloud players such as Symantec, BMC Software and Citrix against their emerging cloud competition,...more

Shook, Hardy & Bacon L.L.P.

Centripetal Takes On Networking Giant Cisco In Patent Fight

In a new twist in competitor-based lawsuits involving cloud computing, Centripetal Networks, a relative newcomer, filed a patent lawsuit against industry incumbent and Fortune 100 Company Cisco in the U.S. District Court for...more

Nutter McClennen & Fish LLP

IP Due Diligence: The Five Questions You Must Ask in Corporate Transactions

Konstantin Linnik, Ph.D., a partner in Nutter’s Intellectual Property Department, addressed the importance of intellectual property due diligence in corporate transactions in Nutter Insights. Konstantin discussed when a...more

Foley & Lardner LLP

Looking Ahead: Top Issues Impacting the Tech Industry in 2017

Foley & Lardner LLP on

As technology continues to reshape how business gets done and the way people live their lives, there are many reasons to be excited about the tech industry’s prospects heading into 2017. The more than 300 executives,...more

McDonnell Boehnen Hulbert & Berghoff LLP

AbbVie v. Amgen: The Litigation Phase for a HUMIRA® Biosimilar Begins

To date, Amgen has been the reference product sponsor for many biosimilar applications. Correspondingly, Amgen has been the Plaintiff in many of the litigations that have been based on the provisions of the Biosimilar Price...more

Morgan Lewis

Additional IP Considerations in Light of Brexit

Morgan Lewis on

Pharmaceutical and agricultural companies in particular should consider the effect of Brexit on their European patent portfolios. Supplementary Protection Certificates (SPCs) are governed by EU regulations and are thus...more

Winstead PC

Unitary Patents, the Unified Patent Court, Opt-Out Timing, Pros and Cons

Winstead PC on

Regardless of the June 23, 2016 vote on Brexit, all owners of European patents, and all applicants seeking patents in Europe, will have both new options, and a new set of important decisions to make. Most commentators...more

Robins Kaplan LLP

Enforcement Challenges For Biotech Patents

Robins Kaplan LLP on

Enforcing intellectual property rights can be a challenging affair, and this is particularly true in the biotech industry. Attorneys Seth Northrop and Matt McFarlane discuss the issues facing biotech patent holders today,...more

McDonnell Boehnen Hulbert & Berghoff LLP

Guest Post: $2.6 Billion Per Drug: Is Your Patent Portfolio Strong Enough to Protect Your Investment?

Late last year, the Tufts Center for the Study of Drug Development (CSDD) released a number that would cause jaws to drop all around the healthcare world.  The estimated cost for developing a new drug was an astounding $2.558...more

26 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide